We verified that B7H6 RNA and protein were expressed by human cancer cell lines of various types and confirmed by immunohistochemistry B7H6 expression in primary tumors, validating B7H6 as an attractive target for immunotherapy. The gene discussed is NCR3LG1; the disease is cancer.